Literature DB >> 14681696

Spontaneous transgenesis of human B lymphocytes.

G Filaci1, M Gerloni, M Rizzi, P Castiglioni, H-D Chang, M C Wheeler, R Fiocca, M Zanetti.   

Abstract

DNA can cross the cell membrane by natural means, but the functional relevance of this phenomenon has not been fully elucidated. Here, we analyzed spontaneous transgenesis of human B cells using plasmid DNA coding for a functional immunoglobulin (Ig) heavy chain gene under the control of a B-cell-specific promoter. Using polymerase chain reaction (PCR), reverse transcriptase-PCR, and flow cytometry in combination, spontaneous transgenesis was documented in Burkitt's lymphoma cell lines, Epstein-Barr virus-transformed cell lines, and peripheral blood B lymphocytes of the mature naïve phenotype (IgM(+)/IgD(+)/CD27(-)). By immunoelectron microscopy, the internalized DNA was seen in the lysosomes/late endosomes and in the cytosol proximal to the nucleus. Importantly, spontaneously transgenic B cells processed and presented to major histocompatibility complex (MHC)-restricted T lymphocytes a peptide expressed in the transgenic product. This is the first demonstration that primary B lymphocytes possess a program for the spontaneous internalization of DNA, which in turn imparts the cell with new immunological functions. As spontaneous transgenesis is obtained using a nonviral vector, does not require prior cell activation, and is not associated with chromosomal integration, the findings reported here open new possibilities for genetic manipulations of mature naïve B lymphocytes for therapy and vaccination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14681696     DOI: 10.1038/sj.gt.3302132

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

Review 1.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice.

Authors:  Francesca Ferrera; Daniela Fenoglio; Maurizio Cutolo; Giuseppe Balbi; Alessia Parodi; Florinda Battaglia; Francesca Kalli; Domenico Barone; Francesco Indiveri; Domenico Criscuolo; Gilberto Filaci
Journal:  Clin Exp Med       Date:  2014-07-25       Impact factor: 3.984

3.  Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

4.  T cell immunity using transgenic B lymphocytes.

Authors:  Mara Gerloni; Marta Rizzi; Paola Castiglioni; Maurizio Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-02       Impact factor: 11.205

5.  Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming.

Authors:  Laura E Johnson; Dirk Brockstedt; Meredith Leong; Peter Lauer; Erin Theisen; John-Demian Sauer; Douglas G McNeel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

Review 6.  Telomerase immunity from bench to bedside: round one.

Authors:  Xochtil Cortez-Gonzalez; Maurizio Zanetti
Journal:  J Transl Med       Date:  2007-02-26       Impact factor: 5.531

7.  Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines.

Authors:  Gregory Lee Szeto; Debra Van Egeren; Hermoon Worku; Armon Sharei; Brian Alejandro; Clara Park; Kirubel Frew; Mavis Brefo; Shirley Mao; Megan Heimann; Robert Langer; Klavs Jensen; Darrell J Irvine
Journal:  Sci Rep       Date:  2015-05-22       Impact factor: 4.379

8.  Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.

Authors:  Evgeniya V Dolgova; Ekaterina A Potter; Anastasiya S Proskurina; Alexandra M Minkevich; Elena R Chernych; Alexandr A Ostanin; Yaroslav R Efremov; Sergey I Bayborodin; Valeriy P Nikolin; Nelly A Popova; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Stem Cell Res Ther       Date:  2016-05-25       Impact factor: 6.832

9.  B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.

Authors:  Viswa Teja Colluru; Douglas G McNeel
Journal:  Oncotarget       Date:  2016-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.